SERIES: Active Medical Product Surveillance Roundtables | Number 15 of 19 « Previous | Next »

Apr 9

Past Event

Developing the Capabilities for Device Surveillance through the Medical Device Epidemiology Network

Event Materials

Audio

Brookings Multimedia content requires JavaScript. Your browser either doesn't have JavaScript or doesn't have it enabled.

Instructions to enable JavaScript.

Summary

On April 9, the Engelberg Center for Health Care Reform hosted a roundtable, “Developing the Capabilities for Device Surveillance through the Medical Device Epidemiology Network.” The Medical Device Epidemiology Network (MDEpiNet) was launched by FDA to develop the infrastructure and methodological approaches for conducting robust analytic studies that will improve FDA’s understanding of medical device performance.

The roundtable featured presentations from Danica Marinac-Dabic, Director, Division of Epidemiology, Office of Surveillance and Biometrics, Center for Devices and Radiological Health, U.S. Food and Drug Administration; Mary Beth Ritchey, Associate Division Director, Division of Epidemiology, Office of Surveillance and Biometrics, Center for Devices and Radiological Health, FDA; Benjamin (Ben) Eloff, Senior Scientific Program Manager, Division of Epidemiology, Office of Surveillance and Biometrics, Center for Devices and Radiological Health, FDA; Frederic (Fred) Resnic, Director, Cardiac Catheterization Laboratory, Brigham and Women’s Hospital and Assistant Professor of Medicine, Harvard Medical School; and Art Sedrakyan, Associate Professor of Public Health, Director, Patient-Centered Comparative Research Program, Weill Cornell Medical College. The presentations included a discussion about MDEpiNet’s role as part of a comprehensive postmarket national medical product surveillance strategy, an update on the current status of MDEpiNet, an overview of its methods and infrastructure work streams, and a discussion about its future direction.

Event Agenda

  • Welcome and Introduction

  • FDA Medical Device Epidemiology Network (MDEpiNet) Initiative

    • Danica Marinac-Dabic

      U.S. Food and Drug Administration

    • Mary Beth Ritchey

      U.S. Food and Drug Administration

    • Benjamin Eloff

      U.S. Food and Drug Administration

    • Fred Resnic

      Brigham and Women’s Hospital and Harvard Medical School

    • Art Sedrakyan

      Weill Cornell Medical College

Details

April 9, 2012

3:30 AM - 4:30 PM EDT

The Brookings Institution

Webinar

1775 Massachusetts Ave., NW

Map

For More Information

Engelberg Events

202.797.4391

SERIES: Active Medical Product Surveillance Roundtables | Number 15